Sylvia S. Gayle - Concepedia

Author

Sylvia S. Gayle

Also Known As

S.S. Gayle, Sylvia Gayle, Sylvia S. Gayle

Publications

241

Citations

H-Index

Concepts

All Affiliations

Sylvia S. Gayle is an author at Case Western Reserve University specializing in breast cancer, cell biology, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	106
2	Cell Biology	2	2	106
3	Pharmacology	1	1	50
4	Cancer Cell Biology	1	1	50
5	Cancer Therapeutics	1	1	50

Sylvia S. Gayle

Publications

220

Citations

H-Index

Page 1

	Year	Citations
Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells Sylvia S. Gayle, Jennifer M. Sahni, Bryan M. Webb, Journal of Biological Chemistry	2018	59
Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases Jennifer M. Sahni, Sylvia S. Gayle, Kristen L. Weber-Bonk, Journal of Biological Chemistry Breast OncologyTriple-negative Breast CancersMedicineBreast CancerAurora Kinases	2016	56
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance Sylvia S. Gayle, Samuel L.M. Arnold, Ruth O’Regan, Anti-Cancer Agents in Medicinal Chemistry Breast OncologyPharmacologic InhibitionPi3k/mtor ActivityMedicinePrimary Trastuzumab Resistance	2012	50
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors Jennifer M. Sahni, Sylvia S. Gayle, Bryan M. Webb, Cancer Research	2017	31
MEK Inhibition Increases Lapatinib Sensitivity Via Modulation of FOXM1 Sylvia S. Gayle, Robert C. Castellino, Meghan C. Buss, Current Medicinal Chemistry	2013	24

Page 1